Could antioxidant supplementation delay progression of cardiovascular disease in end-stage renal disease patients?

S Roumeliotis, A Roumeliotis, X Gorny… - Current vascular …, 2021 - ingentaconnect.com
In end-stage renal disease patients, the leading causes of mortality are of cardiovascular
(CV) origin. The underlying mechanisms are complex, given that sudden heart failure is …
被引用次数：11 相关文章

Could Antioxidant Supplementation Delay Progression of Cardiovascular Disease in End-Stage Renal Disease Patients?

S Roumeliotis, A Roumeliotis, X Gorny… - Current Vascular …, 2021 - europepmc.org
In end-stage renal disease patients, the leading causes of mortality are of cardiovascular
(CV) origin. The underlying mechanisms are complex, given that sudden heart failure is …

Could Antioxidant Supplementation Delay Progression of Cardiovascular Disease in End-Stage Renal Disease Patients?

S Roumeliotis, A Roumeliotis… - Current vascular …, 2021 - pubmed.ncbi.nlm.nih.gov
In end-stage renal disease patients, the leading causes of mortality are of cardiovascular
(CV) origin. The underlying mechanisms are complex, given that sudden heart failure is …